UY24698A1 - PROMOTER REGULATED BY IRON AND USES OF IT - Google Patents

PROMOTER REGULATED BY IRON AND USES OF IT

Info

Publication number
UY24698A1
UY24698A1 UY24698A UY24698A UY24698A1 UY 24698 A1 UY24698 A1 UY 24698A1 UY 24698 A UY24698 A UY 24698A UY 24698 A UY24698 A UY 24698A UY 24698 A1 UY24698 A1 UY 24698A1
Authority
UY
Uruguay
Prior art keywords
iron
sequence
promoter
promoter regulated
regulated
Prior art date
Application number
UY24698A
Other languages
Spanish (es)
Inventor
N Brahmbatt Himanshu
David Emery
Adam Burn
Original Assignee
Commw Scient Ind Res Org
Australian Wool Res And Promotion Organisation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AUPO2164A external-priority patent/AUPO216496A0/en
Priority claimed from AUPO2454A external-priority patent/AUPO245496A0/en
Priority claimed from AUPO7801A external-priority patent/AUPO780197A0/en
Application filed by Commw Scient Ind Res Org, Australian Wool Res And Promotion Organisation filed Critical Commw Scient Ind Res Org
Publication of UY24698A1 publication Critical patent/UY24698A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43536—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from worms
    • C07K14/4354—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from worms from nematodes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/90—Stable introduction of foreign DNA into chromosome
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Mycology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

Invento que proporciona un promotor regulado por hierro y su uso para la expresión de polipéptidos y en particular su uso en vacunas vivas, el cual comprende una secuencia de ADN que incluye la secuencia de los residuos 284 a 409 (figura 1), o una secuencia de ácido nucleico funcionalmente equivalente. También se proporcionan vectores y células huéspedes recombinantes incluyendo el promotor y composiciones utilizadas para inducir una respuesta inmunitaria en un animal.Invention that provides an iron-regulated promoter and its use for the expression of polypeptides and in particular its use in live vaccines, which comprises a DNA sequence that includes the sequence of residues 284 to 409 (Figure 1), or a sequence of functionally equivalent nucleic acid. Recombinant host cells and vectors are also provided including the promoter and compositions used to induce an immune response in an animal.

UY24698A 1996-09-06 1997-09-05 PROMOTER REGULATED BY IRON AND USES OF IT UY24698A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AUPO2164A AUPO216496A0 (en) 1996-09-06 1996-09-06 Inducible promoters
AUPO2454A AUPO245496A0 (en) 1996-09-19 1996-09-19 Site-specific chromosomal integration system
AUPO7801A AUPO780197A0 (en) 1997-07-09 1997-07-09 Site-specific chromosomal integration system incorporating inducible promoter

Publications (1)

Publication Number Publication Date
UY24698A1 true UY24698A1 (en) 1998-02-12

Family

ID=27157946

Family Applications (1)

Application Number Title Priority Date Filing Date
UY24698A UY24698A1 (en) 1996-09-06 1997-09-05 PROMOTER REGULATED BY IRON AND USES OF IT

Country Status (7)

Country Link
EP (1) EP0964924A4 (en)
AR (1) AR008171A1 (en)
BR (1) BR9711692A (en)
CA (1) CA2265883A1 (en)
NZ (1) NZ334649A (en)
UY (1) UY24698A1 (en)
WO (1) WO1998010064A1 (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE190660T1 (en) * 1990-12-18 2000-04-15 Gen Hospital Corp IMPROVED VACCINES
ATE359370T1 (en) * 1993-02-22 2007-05-15 Gen Hospital Corp HETEROLOGUE ANTIGENS IN STRAINS FOR LIVE CELL VACCINATION

Also Published As

Publication number Publication date
AR008171A1 (en) 1999-12-09
EP0964924A4 (en) 2001-04-18
EP0964924A1 (en) 1999-12-22
NZ334649A (en) 2000-08-25
CA2265883A1 (en) 1998-03-12
BR9711692A (en) 2000-10-24
WO1998010064A1 (en) 1998-03-12

Similar Documents

Publication Publication Date Title
AR247590A1 (en) A dna sequence which encodes recombining human factor viii derivatives and a procedure for obtaining them
BR9711123A (en) Leukotoxin-gnrh chimeras
ES2193145T3 (en) CHEMICAL PROCOAGULANTS PROTEINS.
CO4700344A1 (en) POLYNUCLEOTIDIC VACCINE FOR CATTLE BY THE INTRADERMIC ROUTE
CY1105364T1 (en) METHODS AND COMPOSITIONS OF IMMUNE MODULATION
PH25747A (en) Recombinant vaccinia vrus mva
ATE444360T1 (en) T-CELL EPITOPES FROM THE MAIN ALLERGENS OF DERMATOPHAGOIDES (HOUSE MITES)
CY1106350T1 (en) TUBERCULOSIS VACCINE
DZ634A1 (en) Non-toxigenic vibrio cholera mutants.
DK216289A (en) RECOMBINANT - DNA - DIVIDED TABLE TELLA TOXIN SUBSTANCES AND ANALOGUES THEREOF
MX9204685A (en) DNA SEQUENCE CODING AN EXTERNAL SURFACE PROTEIN (OSPA) OR DERIVED FROM THE SAME VACCINE COMPOSITION QE INCLUDES SUCH PROTEIN.
ATE229978T1 (en) HELICOBACTER PROTEINS AND VACCINES
ES2103928T3 (en) MYCOBACTERIUM POLYPEPTIDES AND NUCLEIC ACIDS THAT CODE THEM USED IN THE DIAGNOSIS AND TREATMENT OF TUBERCULOSIS.
CY1107570T1 (en) IMAGE MAGNETIC POLYPeptides CODED BY MAGE MININGS AND THEIR USES
DK251890A (en) POLYPEPTID AND ITS USE AND EXPRESSION SYSTEM FOR ITS EXPRESSION
NO975730L (en) Method of increasing protective immune responses
IT1262895B (en) Protein extracted from cytotoxic strains of Helicobacter pylori, gene expressing it, use of the protein as a vaccine or for diagnostic purposes.
DK0588578T3 (en) immunogens
NL980006I1 (en) Antigenic preparations and isolation of such preparations.
NO20002504D0 (en) Adenovirus vectors and method of reducing homologous recombination phenomena
DK0425082T3 (en) vaccines
DE60042816D1 (en) T HELPER CELL EPITOPE
NZ238833A (en) Equine herpesvirus-4 gh or gc polypeptides, nucleic acids encoding them and vaccines therefrom
UY24698A1 (en) PROMOTER REGULATED BY IRON AND USES OF IT
BR9710849A (en) Vaccine containing a peroxy-redoxin and / or a beta-tubulin.

Legal Events

Date Code Title Description
RDES Application refused

Effective date: 20041027